PRMT5通过甲基化激活KLF5以促进肺癌的发生
Hai Zhou1, Jing Chang1, Jingjian Zhang1
1Department of Respiratory and Critical Care Medicine, Shidong Hospital of Yangpu District, Shanghai, China.
Journal of cellular and molecular medicine
|July 18, 2023
概括
蛋白质氨酸甲基转移酶5 (PRMT5) 通过甲基化克鲁佩尔样因子5 (KLF5) 促进肺癌,防止其降解. 针对这种PRMT5/KLF5相互作用可能会提供新的肺癌疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 克鲁佩尔样因子5 (KLF5) 是一种促进肺癌进展的致癌因子.
- 对于KLF5的翻译后修改并没有很好地理解.
- 蛋白质氨酸甲基转移酶5 (PRMT5) 是一种瘤基因,与各种癌症有关.
研究的目的:
- 为了研究PRMT5和KLF5在肺癌中的相互作用.
- 阐明PRMT5介导的KLF5修饰在肺癌发病过程中的作用.
- 探索针对PRMT5/KLF5轴的治疗潜力.
主要方法:
- 西方涂抹以评估蛋白质表达水平.
- 同免疫沉以确认PRMT5-KLF5相互作用.
- 在体外和体内实验中涉及PRMT5下调或抑制的实验.
- 下游目标基因表达和信号通路的分析 (Akt/GSK3β).
主要成果:
- 在肺癌中,PRMT5和KLF5都高度表达.
- PRMT5直接与KLF5相互作用,并将其二甲基化为阿基因41.
- 通过PRMT5介导的KLF5二甲基化稳定了KLF5,促进了肺癌细胞的维持和增殖.
- 抑制PRMT5会降低KLF5水平及其下游标,抑制癌症的生长.
结论:
- PRMT5甲基化KLF5,防止其降解并促进肺癌细胞的增殖.
- PRMT5/KLF5轴对肺癌的维持至关重要.
- 向PRMT5可能是肺癌的可行治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K


